Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma

Name: Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
Published: 2023
License: Public Domain

European Organisation for Research and Treatment of Cancer - EORTC · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

stage ib-iib cutaneous t-cell lymphoma, cutaneous t-cell lymphoma, mogamulizumab, total skin electron beam therapy, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma

Related documents